DYNAVAX TECHNOLOGIES news, videos and press releases
For more news please use our advanced search feature.
DYNAVAX TECHNOLOGIES - More news...
DYNAVAX TECHNOLOGIES - More news...
- Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting
- Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom
- Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting
- Dynavax Comments on Glass Lewis Recommendation
- Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies
- Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees
- Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting
- Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value
- /C O R R E C T I O N -- Dynavax Technologies/
- Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum
- Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs
- Deep Track Capital Releases Investor Presentation on Dynavax Technologies
- Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits
- Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
- Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
- Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders
- Deep Track Capital Comments on Dynavax Technologies’ Rejection of Most Recent Settlement Offer
- Dynavax Files Preliminary Proxy Statement
- Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors
- Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase
- Dynavax to Participate in Upcoming Investor Conferences
- Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance
- Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy
- Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
- Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025
- Dynavax Advances Board Refreshment Program
- Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
- Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
- Dynavax Announces $100 Million Accelerated Share Repurchase Program
- Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates
